Toronto Dominion Bank’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Toronto Dominion Bank’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.81K	Hold	21,635	–	–	﹤0.01%	2157
2026 Q1	$1.62K	Hold	21,635	–	–	﹤0.01%	2009
2025 Q4	$1.08K	Sell	21,635 -14,180	-40%	-$1.47K	﹤0.01%	1932
2025 Q3	$1.86K	Hold	35,815	–	–	﹤0.01%	1823
2025 Q2	$1.7K	Buy	+35,815	New	+$1.8K	﹤0.01%	1697

Other funds holding ESLAW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $128M AUM 19.21% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Toronto Dominion Bank's ESLAW Position: Q2 2026 in Review

Toronto Dominion Bank held its Estrella Immunopharma Warrant (ESLAW) position steady in Q2 2026 at 21,635 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

Toronto Dominion Bank first reported a position in ESLAW in Q2 2025 and has held it in 5 quarters since. 8 funds tracked by Wall St. Rank hold ESLAW as of Q2 2026.

Toronto Dominion Bank held 21,635 shares of Estrella Immunopharma Warrant worth $2.81K as of Q2 2026.
Toronto Dominion Bank left its Estrella Immunopharma Warrant share count unchanged in Q2 2026.
Estrella Immunopharma Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2157 holding.
Toronto Dominion Bank first reported a position in Estrella Immunopharma Warrant in Q2 2025 and has held it in 5 quarters since.
8 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.